http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 08 Jul 2026 07:35:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Conavi+Medical+Announces+JSCAI+Publication+Demonstrating+the+Clinical+Utility+of+Hybrid+IVUS+OCT+Imaging/26744277.html <p>TORONTO, July 08, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced the publication of a case report in the <em>Journal of the Society for Cardiovascular Angiography &amp; Interventions</em> (“JSCAI”) titled “Versatility of Hybrid OCT and IVUS Imaging Enhances Contrast-Sparing Management of Eruptive Calcified Nodules.” The publication features Conavi’s hybrid intravascular ultrasound (“IVUS”) and optical coherence tomography (“OCT”) imaging system in a complex coronary procedure involving a patient with impaired renal function, http://www.streetinsider.com/Press+Releases/Conavi+Medical+Announces+JSCAI+Publication+Demonstrating+the+Clinical+Utility+of+Hybrid+IVUS+OCT+Imaging/26744277.html Wed, 08 Jul 2026 07:35:00 -0400 A.06822034 A.29121491 CNVI CNVIF O.07072321 O.20026344 O.29940178 http://www.streetinsider.com/Press+Releases/Conavi+Medical+Announces+JSCAI+Publication+Demonstrating+the+Clinical+Utility+of+Hybrid+IVUS+OCT+Imaging/26744277.html <p>TORONTO, July 08, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced the publication of a case report in the <em>Journal of the Society for Cardiovascular Angiography &amp; Interventions</em> (“JSCAI”) titled “Versatility of Hybrid OCT and IVUS Imaging Enhances Contrast-Sparing Management of Eruptive Calcified Nodules.” The publication features Conavi’s hybrid intravascular ultrasound (“IVUS”) and optical coherence tomography (“OCT”) imaging system in a complex coronary procedure involving a patient with impaired renal function, http://www.streetinsider.com/Press+Releases/Conavi+Medical+Announces+JSCAI+Publication+Demonstrating+the+Clinical+Utility+of+Hybrid+IVUS+OCT+Imaging/26744277.html Wed, 08 Jul 2026 07:35:00 -0400 A.06822034 A.29121491 CNVI CNVIF O.07072321 O.20026344 O.29940178 http://www.streetinsider.com/Press+Releases/Conavi+Medical+Announces+JSCAI+Publication+Demonstrating+the+Clinical+Utility+of+Hybrid+IVUS+OCT+Imaging/26744277.html <p>TORONTO, July 08, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced the publication of a case report in the <em>Journal of the Society for Cardiovascular Angiography &amp; Interventions</em> (“JSCAI”) titled “Versatility of Hybrid OCT and IVUS Imaging Enhances Contrast-Sparing Management of Eruptive Calcified Nodules.” The publication features Conavi’s hybrid intravascular ultrasound (“IVUS”) and optical coherence tomography (“OCT”) imaging system in a complex coronary procedure involving a patient with impaired renal function, http://www.streetinsider.com/Press+Releases/Conavi+Medical+Announces+JSCAI+Publication+Demonstrating+the+Clinical+Utility+of+Hybrid+IVUS+OCT+Imaging/26744277.html Wed, 08 Jul 2026 07:35:00 -0400 A.06822034 A.29121491 CNVI CNVIF O.07072321 O.20026344 O.29940178 http://www.streetinsider.com/Press+Releases/Conavi+Medical+Announces+JSCAI+Publication+Demonstrating+the+Clinical+Utility+of+Hybrid+IVUS+OCT+Imaging/26744277.html <p>TORONTO, July 08, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced the publication of a case report in the <em>Journal of the Society for Cardiovascular Angiography &amp; Interventions</em> (“JSCAI”) titled “Versatility of Hybrid OCT and IVUS Imaging Enhances Contrast-Sparing Management of Eruptive Calcified Nodules.” The publication features Conavi’s hybrid intravascular ultrasound (“IVUS”) and optical coherence tomography (“OCT”) imaging system in a complex coronary procedure involving a patient with impaired renal function, http://www.streetinsider.com/Press+Releases/Conavi+Medical+Announces+JSCAI+Publication+Demonstrating+the+Clinical+Utility+of+Hybrid+IVUS+OCT+Imaging/26744277.html Wed, 08 Jul 2026 07:35:00 -0400 A.06822034 A.29121491 CNVI CNVIF O.07072321 O.20026344 O.29940178 http://www.streetinsider.com/Press+Releases/Conavi+Medical+Announces+JSCAI+Publication+Demonstrating+the+Clinical+Utility+of+Hybrid+IVUS+OCT+Imaging/26744277.html <p>TORONTO, July 08, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced the publication of a case report in the <em>Journal of the Society for Cardiovascular Angiography &amp; Interventions</em> (“JSCAI”) titled “Versatility of Hybrid OCT and IVUS Imaging Enhances Contrast-Sparing Management of Eruptive Calcified Nodules.” The publication features Conavi’s hybrid intravascular ultrasound (“IVUS”) and optical coherence tomography (“OCT”) imaging system in a complex coronary procedure involving a patient with impaired renal function, http://www.streetinsider.com/Press+Releases/Conavi+Medical+Announces+JSCAI+Publication+Demonstrating+the+Clinical+Utility+of+Hybrid+IVUS+OCT+Imaging/26744277.html Wed, 08 Jul 2026 07:35:00 -0400 A.06822034 A.29121491 CNVI CNVIF O.07072321 O.20026344 O.29940178 http://www.streetinsider.com/Press+Releases/Conavi+Medical+Announces+JSCAI+Publication+Demonstrating+the+Clinical+Utility+of+Hybrid+IVUS+OCT+Imaging/26744277.html <p>TORONTO, July 08, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced the publication of a case report in the <em>Journal of the Society for Cardiovascular Angiography &amp; Interventions</em> (“JSCAI”) titled “Versatility of Hybrid OCT and IVUS Imaging Enhances Contrast-Sparing Management of Eruptive Calcified Nodules.” The publication features Conavi’s hybrid intravascular ultrasound (“IVUS”) and optical coherence tomography (“OCT”) imaging system in a complex coronary procedure involving a patient with impaired renal function, http://www.streetinsider.com/Press+Releases/Conavi+Medical+Announces+JSCAI+Publication+Demonstrating+the+Clinical+Utility+of+Hybrid+IVUS+OCT+Imaging/26744277.html Wed, 08 Jul 2026 07:35:00 -0400 A.06822034 A.29121491 CNVI CNVIF O.07072321 O.20026344 O.29940178 http://www.streetinsider.com/Press+Releases/Conavi+Medical+Announces+JSCAI+Publication+Demonstrating+the+Clinical+Utility+of+Hybrid+IVUS+OCT+Imaging/26744277.html <p>TORONTO, July 08, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced the publication of a case report in the <em>Journal of the Society for Cardiovascular Angiography &amp; Interventions</em> (“JSCAI”) titled “Versatility of Hybrid OCT and IVUS Imaging Enhances Contrast-Sparing Management of Eruptive Calcified Nodules.” The publication features Conavi’s hybrid intravascular ultrasound (“IVUS”) and optical coherence tomography (“OCT”) imaging system in a complex coronary procedure involving a patient with impaired renal function, http://www.streetinsider.com/Press+Releases/Conavi+Medical+Announces+JSCAI+Publication+Demonstrating+the+Clinical+Utility+of+Hybrid+IVUS+OCT+Imaging/26744277.html Wed, 08 Jul 2026 07:35:00 -0400 A.06822034 A.29121491 CNVI CNVIF O.07072321 O.20026344 O.29940178 http://www.streetinsider.com/Globe+Newswire/Conavi+Medical+Announces+JSCAI+Publication+Demonstrating+the+Clinical+Utility+of+Hybrid+IVUS+OCT+Imaging/26744277.html <p>TORONTO, July 08, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced the publication of a case report in the <em>Journal of the Society for Cardiovascular Angiography &amp; Interventions</em> (“JSCAI”) titled “Versatility of Hybrid OCT and IVUS Imaging Enhances Contrast-Sparing Management of Eruptive Calcified Nodules.” The publication features Conavi’s hybrid intravascular ultrasound (“IVUS”) and optical coherence tomography (“OCT”) imaging system in a complex coronary procedure involving a patient with impaired renal function, http://www.streetinsider.com/Globe+Newswire/Conavi+Medical+Announces+JSCAI+Publication+Demonstrating+the+Clinical+Utility+of+Hybrid+IVUS+OCT+Imaging/26744277.html Wed, 08 Jul 2026 07:35:00 -0400 A.06822034 A.29121491 CNVI CNVIF O.07072321 O.20026344 O.29940178 http://www.streetinsider.com/Globe+Newswire/Conavi+Medical+Announces+JSCAI+Publication+Demonstrating+the+Clinical+Utility+of+Hybrid+IVUS+OCT+Imaging/26744277.html <p>TORONTO, July 08, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced the publication of a case report in the <em>Journal of the Society for Cardiovascular Angiography &amp; Interventions</em> (“JSCAI”) titled “Versatility of Hybrid OCT and IVUS Imaging Enhances Contrast-Sparing Management of Eruptive Calcified Nodules.” The publication features Conavi’s hybrid intravascular ultrasound (“IVUS”) and optical coherence tomography (“OCT”) imaging system in a complex coronary procedure involving a patient with impaired renal function, http://www.streetinsider.com/Globe+Newswire/Conavi+Medical+Announces+JSCAI+Publication+Demonstrating+the+Clinical+Utility+of+Hybrid+IVUS+OCT+Imaging/26744277.html Wed, 08 Jul 2026 07:35:00 -0400 A.06822034 A.29121491 CNVI CNVIF O.07072321 O.20026344 O.29940178 http://www.streetinsider.com/Globe+Newswire/Conavi+Medical+Announces+JSCAI+Publication+Demonstrating+the+Clinical+Utility+of+Hybrid+IVUS+OCT+Imaging/26744277.html <p>TORONTO, July 08, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced the publication of a case report in the <em>Journal of the Society for Cardiovascular Angiography &amp; Interventions</em> (“JSCAI”) titled “Versatility of Hybrid OCT and IVUS Imaging Enhances Contrast-Sparing Management of Eruptive Calcified Nodules.” The publication features Conavi’s hybrid intravascular ultrasound (“IVUS”) and optical coherence tomography (“OCT”) imaging system in a complex coronary procedure involving a patient with impaired renal function, http://www.streetinsider.com/Globe+Newswire/Conavi+Medical+Announces+JSCAI+Publication+Demonstrating+the+Clinical+Utility+of+Hybrid+IVUS+OCT+Imaging/26744277.html Wed, 08 Jul 2026 07:35:00 -0400 A.06822034 A.29121491 CNVI CNVIF O.07072321 O.20026344 O.29940178 http://www.streetinsider.com/Globe+Newswire/Conavi+Medical+Announces+JSCAI+Publication+Demonstrating+the+Clinical+Utility+of+Hybrid+IVUS+OCT+Imaging/26744277.html <p>TORONTO, July 08, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced the publication of a case report in the <em>Journal of the Society for Cardiovascular Angiography &amp; Interventions</em> (“JSCAI”) titled “Versatility of Hybrid OCT and IVUS Imaging Enhances Contrast-Sparing Management of Eruptive Calcified Nodules.” The publication features Conavi’s hybrid intravascular ultrasound (“IVUS”) and optical coherence tomography (“OCT”) imaging system in a complex coronary procedure involving a patient with impaired renal function, http://www.streetinsider.com/Globe+Newswire/Conavi+Medical+Announces+JSCAI+Publication+Demonstrating+the+Clinical+Utility+of+Hybrid+IVUS+OCT+Imaging/26744277.html Wed, 08 Jul 2026 07:35:00 -0400 A.06822034 A.29121491 CNVI CNVIF O.07072321 O.20026344 O.29940178 http://www.streetinsider.com/Globe+Newswire/Conavi+Medical+Announces+JSCAI+Publication+Demonstrating+the+Clinical+Utility+of+Hybrid+IVUS+OCT+Imaging/26744277.html <p>TORONTO, July 08, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced the publication of a case report in the <em>Journal of the Society for Cardiovascular Angiography &amp; Interventions</em> (“JSCAI”) titled “Versatility of Hybrid OCT and IVUS Imaging Enhances Contrast-Sparing Management of Eruptive Calcified Nodules.” The publication features Conavi’s hybrid intravascular ultrasound (“IVUS”) and optical coherence tomography (“OCT”) imaging system in a complex coronary procedure involving a patient with impaired renal function, http://www.streetinsider.com/Globe+Newswire/Conavi+Medical+Announces+JSCAI+Publication+Demonstrating+the+Clinical+Utility+of+Hybrid+IVUS+OCT+Imaging/26744277.html Wed, 08 Jul 2026 07:35:00 -0400 A.06822034 A.29121491 CNVI CNVIF O.07072321 O.20026344 O.29940178 http://www.streetinsider.com/Globe+Newswire/Conavi+Medical+Announces+JSCAI+Publication+Demonstrating+the+Clinical+Utility+of+Hybrid+IVUS+OCT+Imaging/26744277.html <p>TORONTO, July 08, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced the publication of a case report in the <em>Journal of the Society for Cardiovascular Angiography &amp; Interventions</em> (“JSCAI”) titled “Versatility of Hybrid OCT and IVUS Imaging Enhances Contrast-Sparing Management of Eruptive Calcified Nodules.” The publication features Conavi’s hybrid intravascular ultrasound (“IVUS”) and optical coherence tomography (“OCT”) imaging system in a complex coronary procedure involving a patient with impaired renal function, http://www.streetinsider.com/Globe+Newswire/Conavi+Medical+Announces+JSCAI+Publication+Demonstrating+the+Clinical+Utility+of+Hybrid+IVUS+OCT+Imaging/26744277.html Wed, 08 Jul 2026 07:35:00 -0400 A.06822034 A.29121491 CNVI CNVIF O.07072321 O.20026344 O.29940178 http://www.streetinsider.com/Globe+Newswire/Conavi+Medical+Announces+JSCAI+Publication+Demonstrating+the+Clinical+Utility+of+Hybrid+IVUS+OCT+Imaging/26744277.html <p>TORONTO, July 08, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced the publication of a case report in the <em>Journal of the Society for Cardiovascular Angiography &amp; Interventions</em> (“JSCAI”) titled “Versatility of Hybrid OCT and IVUS Imaging Enhances Contrast-Sparing Management of Eruptive Calcified Nodules.” The publication features Conavi’s hybrid intravascular ultrasound (“IVUS”) and optical coherence tomography (“OCT”) imaging system in a complex coronary procedure involving a patient with impaired renal function, http://www.streetinsider.com/Globe+Newswire/Conavi+Medical+Announces+JSCAI+Publication+Demonstrating+the+Clinical+Utility+of+Hybrid+IVUS+OCT+Imaging/26744277.html Wed, 08 Jul 2026 07:35:00 -0400 A.06822034 A.29121491 CNVI CNVIF O.07072321 O.20026344 O.29940178 http://www.streetinsider.com/Press+Releases/Conavi+Medical+Receives+%241.25+Million+Milestone+Payment%C2%A0Under+Ontario+Life+Sciences+Scale-Up+Fund/26701841.html <p>TORONTO, June 29, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (“Conavi” or the “Company”) (TSXV: CNVI; OTCQB: CNVIF), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced that it has received a milestone payment of $1.25 million from the Province of Ontario through the Life Sciences Scale-Up Fund (&quot;LSSUF&quot;). The milestone payment was triggered by Conavi’s achievement of U.S. FDA 510(k) clearance for its hybrid imaging system — the first system to co-register and co-align intravascular ultrasound (IVUS) and optical coherence tomography (OCT) imaging beams to http://www.streetinsider.com/Press+Releases/Conavi+Medical+Receives+%241.25+Million+Milestone+Payment%C2%A0Under+Ontario+Life+Sciences+Scale-Up+Fund/26701841.html Mon, 29 Jun 2026 07:00:00 -0400 A.29121491 A.50201113 CNVI CNVIF O.03299703 O.07072321 O.29940178 http://www.streetinsider.com/Press+Releases/Conavi+Medical+Receives+%241.25+Million+Milestone+Payment%C2%A0Under+Ontario+Life+Sciences+Scale-Up+Fund/26701841.html <p>TORONTO, June 29, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (“Conavi” or the “Company”) (TSXV: CNVI; OTCQB: CNVIF), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced that it has received a milestone payment of $1.25 million from the Province of Ontario through the Life Sciences Scale-Up Fund (&quot;LSSUF&quot;). The milestone payment was triggered by Conavi’s achievement of U.S. FDA 510(k) clearance for its hybrid imaging system — the first system to co-register and co-align intravascular ultrasound (IVUS) and optical coherence tomography (OCT) imaging beams to http://www.streetinsider.com/Press+Releases/Conavi+Medical+Receives+%241.25+Million+Milestone+Payment%C2%A0Under+Ontario+Life+Sciences+Scale-Up+Fund/26701841.html Mon, 29 Jun 2026 07:00:00 -0400 A.29121491 A.50201113 CNVI CNVIF O.03299703 O.07072321 O.29940178 http://www.streetinsider.com/Press+Releases/Conavi+Medical+Receives+%241.25+Million+Milestone+Payment%C2%A0Under+Ontario+Life+Sciences+Scale-Up+Fund/26701841.html <p>TORONTO, June 29, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (“Conavi” or the “Company”) (TSXV: CNVI; OTCQB: CNVIF), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced that it has received a milestone payment of $1.25 million from the Province of Ontario through the Life Sciences Scale-Up Fund (&quot;LSSUF&quot;). The milestone payment was triggered by Conavi’s achievement of U.S. FDA 510(k) clearance for its hybrid imaging system — the first system to co-register and co-align intravascular ultrasound (IVUS) and optical coherence tomography (OCT) imaging beams to http://www.streetinsider.com/Press+Releases/Conavi+Medical+Receives+%241.25+Million+Milestone+Payment%C2%A0Under+Ontario+Life+Sciences+Scale-Up+Fund/26701841.html Mon, 29 Jun 2026 07:00:00 -0400 A.29121491 A.50201113 CNVI CNVIF O.03299703 O.07072321 O.29940178 http://www.streetinsider.com/Press+Releases/Conavi+Medical+Receives+%241.25+Million+Milestone+Payment%C2%A0Under+Ontario+Life+Sciences+Scale-Up+Fund/26701841.html <p>TORONTO, June 29, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (“Conavi” or the “Company”) (TSXV: CNVI; OTCQB: CNVIF), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced that it has received a milestone payment of $1.25 million from the Province of Ontario through the Life Sciences Scale-Up Fund (&quot;LSSUF&quot;). The milestone payment was triggered by Conavi’s achievement of U.S. FDA 510(k) clearance for its hybrid imaging system — the first system to co-register and co-align intravascular ultrasound (IVUS) and optical coherence tomography (OCT) imaging beams to http://www.streetinsider.com/Press+Releases/Conavi+Medical+Receives+%241.25+Million+Milestone+Payment%C2%A0Under+Ontario+Life+Sciences+Scale-Up+Fund/26701841.html Mon, 29 Jun 2026 07:00:00 -0400 A.29121491 A.50201113 CNVI CNVIF O.03299703 O.07072321 O.29940178 http://www.streetinsider.com/Press+Releases/Conavi+Medical+Receives+%241.25+Million+Milestone+Payment%C2%A0Under+Ontario+Life+Sciences+Scale-Up+Fund/26701841.html <p>TORONTO, June 29, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (“Conavi” or the “Company”) (TSXV: CNVI; OTCQB: CNVIF), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced that it has received a milestone payment of $1.25 million from the Province of Ontario through the Life Sciences Scale-Up Fund (&quot;LSSUF&quot;). The milestone payment was triggered by Conavi’s achievement of U.S. FDA 510(k) clearance for its hybrid imaging system — the first system to co-register and co-align intravascular ultrasound (IVUS) and optical coherence tomography (OCT) imaging beams to http://www.streetinsider.com/Press+Releases/Conavi+Medical+Receives+%241.25+Million+Milestone+Payment%C2%A0Under+Ontario+Life+Sciences+Scale-Up+Fund/26701841.html Mon, 29 Jun 2026 07:00:00 -0400 A.29121491 A.50201113 CNVI CNVIF O.03299703 O.07072321 O.29940178 http://www.streetinsider.com/Press+Releases/Conavi+Medical+Receives+%241.25+Million+Milestone+Payment%C2%A0Under+Ontario+Life+Sciences+Scale-Up+Fund/26701841.html <p>TORONTO, June 29, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (“Conavi” or the “Company”) (TSXV: CNVI; OTCQB: CNVIF), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced that it has received a milestone payment of $1.25 million from the Province of Ontario through the Life Sciences Scale-Up Fund (&quot;LSSUF&quot;). The milestone payment was triggered by Conavi’s achievement of U.S. FDA 510(k) clearance for its hybrid imaging system — the first system to co-register and co-align intravascular ultrasound (IVUS) and optical coherence tomography (OCT) imaging beams to http://www.streetinsider.com/Press+Releases/Conavi+Medical+Receives+%241.25+Million+Milestone+Payment%C2%A0Under+Ontario+Life+Sciences+Scale-Up+Fund/26701841.html Mon, 29 Jun 2026 07:00:00 -0400 A.29121491 A.50201113 CNVI CNVIF O.03299703 O.07072321 O.29940178 http://www.streetinsider.com/Press+Releases/Conavi+Medical+Receives+%241.25+Million+Milestone+Payment%C2%A0Under+Ontario+Life+Sciences+Scale-Up+Fund/26701841.html <p>TORONTO, June 29, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (“Conavi” or the “Company”) (TSXV: CNVI; OTCQB: CNVIF), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced that it has received a milestone payment of $1.25 million from the Province of Ontario through the Life Sciences Scale-Up Fund (&quot;LSSUF&quot;). The milestone payment was triggered by Conavi’s achievement of U.S. FDA 510(k) clearance for its hybrid imaging system — the first system to co-register and co-align intravascular ultrasound (IVUS) and optical coherence tomography (OCT) imaging beams to http://www.streetinsider.com/Press+Releases/Conavi+Medical+Receives+%241.25+Million+Milestone+Payment%C2%A0Under+Ontario+Life+Sciences+Scale-Up+Fund/26701841.html Mon, 29 Jun 2026 07:00:00 -0400 A.29121491 A.50201113 CNVI CNVIF O.03299703 O.07072321 O.29940178 http://www.streetinsider.com/Globe+Newswire/Conavi+Medical+Receives+%241.25+Million+Milestone+Payment%C2%A0Under+Ontario+Life+Sciences+Scale-Up+Fund/26701841.html <p>TORONTO, June 29, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (“Conavi” or the “Company”) (TSXV: CNVI; OTCQB: CNVIF), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced that it has received a milestone payment of $1.25 million from the Province of Ontario through the Life Sciences Scale-Up Fund (&quot;LSSUF&quot;). The milestone payment was triggered by Conavi’s achievement of U.S. FDA 510(k) clearance for its hybrid imaging system — the first system to co-register and co-align intravascular ultrasound (IVUS) and optical coherence tomography (OCT) imaging beams to http://www.streetinsider.com/Globe+Newswire/Conavi+Medical+Receives+%241.25+Million+Milestone+Payment%C2%A0Under+Ontario+Life+Sciences+Scale-Up+Fund/26701841.html Mon, 29 Jun 2026 07:00:00 -0400 A.29121491 A.50201113 CNVI CNVIF O.03299703 O.07072321 O.29940178 http://www.streetinsider.com/Globe+Newswire/Conavi+Medical+Receives+%241.25+Million+Milestone+Payment%C2%A0Under+Ontario+Life+Sciences+Scale-Up+Fund/26701841.html <p>TORONTO, June 29, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (“Conavi” or the “Company”) (TSXV: CNVI; OTCQB: CNVIF), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced that it has received a milestone payment of $1.25 million from the Province of Ontario through the Life Sciences Scale-Up Fund (&quot;LSSUF&quot;). The milestone payment was triggered by Conavi’s achievement of U.S. FDA 510(k) clearance for its hybrid imaging system — the first system to co-register and co-align intravascular ultrasound (IVUS) and optical coherence tomography (OCT) imaging beams to http://www.streetinsider.com/Globe+Newswire/Conavi+Medical+Receives+%241.25+Million+Milestone+Payment%C2%A0Under+Ontario+Life+Sciences+Scale-Up+Fund/26701841.html Mon, 29 Jun 2026 07:00:00 -0400 A.29121491 A.50201113 CNVI CNVIF O.03299703 O.07072321 O.29940178 http://www.streetinsider.com/Globe+Newswire/Conavi+Medical+Receives+%241.25+Million+Milestone+Payment%C2%A0Under+Ontario+Life+Sciences+Scale-Up+Fund/26701841.html <p>TORONTO, June 29, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (“Conavi” or the “Company”) (TSXV: CNVI; OTCQB: CNVIF), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced that it has received a milestone payment of $1.25 million from the Province of Ontario through the Life Sciences Scale-Up Fund (&quot;LSSUF&quot;). The milestone payment was triggered by Conavi’s achievement of U.S. FDA 510(k) clearance for its hybrid imaging system — the first system to co-register and co-align intravascular ultrasound (IVUS) and optical coherence tomography (OCT) imaging beams to http://www.streetinsider.com/Globe+Newswire/Conavi+Medical+Receives+%241.25+Million+Milestone+Payment%C2%A0Under+Ontario+Life+Sciences+Scale-Up+Fund/26701841.html Mon, 29 Jun 2026 07:00:00 -0400 A.29121491 A.50201113 CNVI CNVIF O.03299703 O.07072321 O.29940178 http://www.streetinsider.com/Globe+Newswire/Conavi+Medical+Receives+%241.25+Million+Milestone+Payment%C2%A0Under+Ontario+Life+Sciences+Scale-Up+Fund/26701841.html <p>TORONTO, June 29, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (“Conavi” or the “Company”) (TSXV: CNVI; OTCQB: CNVIF), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced that it has received a milestone payment of $1.25 million from the Province of Ontario through the Life Sciences Scale-Up Fund (&quot;LSSUF&quot;). The milestone payment was triggered by Conavi’s achievement of U.S. FDA 510(k) clearance for its hybrid imaging system — the first system to co-register and co-align intravascular ultrasound (IVUS) and optical coherence tomography (OCT) imaging beams to http://www.streetinsider.com/Globe+Newswire/Conavi+Medical+Receives+%241.25+Million+Milestone+Payment%C2%A0Under+Ontario+Life+Sciences+Scale-Up+Fund/26701841.html Mon, 29 Jun 2026 07:00:00 -0400 A.29121491 A.50201113 CNVI CNVIF O.03299703 O.07072321 O.29940178